The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The fund is non-diversified.
Frequently asked questions
What is the iShares U.S. Pharmaceuticals ETF (IHE) expense ratio?
The iShares U.S. Pharmaceuticals ETF funds expense ratio is 0.4%.
What is iShares U.S. Pharmaceuticals ETF (IHE) current stock price?
As of the latest data, iShares U.S. Pharmaceuticals ETF stock price is $107.41, with a previous close of $106.80. iShares U.S. Pharmaceuticals ETF gained $0.61 in the last trading session, representing a 0.57% increase.
Does iShares U.S. Pharmaceuticals ETF (IHE) pay dividends?
Yes. iShares U.S. Pharmaceuticals ETF pays quarterly dividends with an annualized yield of 1.36% and an estimated annual payout of $1.47 per share.